PL3439647T3 - Kompozycja do zastosowania w zmniejszaniu lub zapobieganiu ogólnemu opóźnieniu rozwojowemu u dzieci - Google Patents

Kompozycja do zastosowania w zmniejszaniu lub zapobieganiu ogólnemu opóźnieniu rozwojowemu u dzieci

Info

Publication number
PL3439647T3
PL3439647T3 PL16730030.0T PL16730030T PL3439647T3 PL 3439647 T3 PL3439647 T3 PL 3439647T3 PL 16730030 T PL16730030 T PL 16730030T PL 3439647 T3 PL3439647 T3 PL 3439647T3
Authority
PL
Poland
Prior art keywords
children
reducing
composition
developmental delay
preventing global
Prior art date
Application number
PL16730030.0T
Other languages
English (en)
Inventor
Ruurd VAN ELBURG
Arjen Paul VOS
Danielle Stefanie COUNOTTE
Ana Renée Pascale SMORENBURG
Original Assignee
N.V. Nutricia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56134528&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3439647(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N.V. Nutricia filed Critical N.V. Nutricia
Publication of PL3439647T3 publication Critical patent/PL3439647T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
PL16730030.0T 2016-04-04 2016-04-04 Kompozycja do zastosowania w zmniejszaniu lub zapobieganiu ogólnemu opóźnieniu rozwojowemu u dzieci PL3439647T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2016/050232 WO2017176109A1 (en) 2016-04-04 2016-04-04 Method for reducing or preventing global developmental delay in children

Publications (1)

Publication Number Publication Date
PL3439647T3 true PL3439647T3 (pl) 2023-08-14

Family

ID=56134528

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16730030.0T PL3439647T3 (pl) 2016-04-04 2016-04-04 Kompozycja do zastosowania w zmniejszaniu lub zapobieganiu ogólnemu opóźnieniu rozwojowemu u dzieci

Country Status (5)

Country Link
US (1) US20190151273A1 (pl)
EP (1) EP3439647B1 (pl)
ES (1) ES2947592T3 (pl)
PL (1) PL3439647T3 (pl)
WO (1) WO2017176109A1 (pl)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050203053A1 (en) 1999-07-30 2005-09-15 Wurtman Richard J. Uridine administration improves phosphatide synthesis, synaptic transmission and cogntive function
ES2294850T3 (es) 1998-07-31 2008-04-01 Massachusetts Institute Of Technology Tratamiento de la enfermedad de alzheimer mediante el aumento de los niveles de citidina in vivo.
US8314064B2 (en) 1998-07-31 2012-11-20 Massachusetts Institute Of Technology Uridine administration stimulates membrane production
US6596302B2 (en) * 2000-04-13 2003-07-22 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
WO2012125020A1 (en) 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma
US20140199265A1 (en) 2013-01-11 2014-07-17 Mead Johnson Nutrition Company Nutritional compositions containing a neurologic component and uses thereof

Also Published As

Publication number Publication date
WO2017176109A1 (en) 2017-10-12
EP3439647B1 (en) 2023-03-22
EP3439647A1 (en) 2019-02-13
ES2947592T3 (es) 2023-08-11
US20190151273A1 (en) 2019-05-23

Similar Documents

Publication Publication Date Title
GB2567273B (en) Compounds for use in reducing liver fat
GB201804800D0 (en) Compositions for providing agents that degrade in water
HK1254371A1 (zh) 粘彈性組合物
GB201600075D0 (en) Immunogenci composition
HUE049443T2 (hu) Egyesített hatású additív készítmény
GB201602626D0 (en) Glycemic reducing composition
GB201612658D0 (en) Composition
GB201612359D0 (en) Composition
GB201611782D0 (en) Composition
GB201510151D0 (en) Non-corrosive foaming composition
PL3439647T3 (pl) Kompozycja do zastosowania w zmniejszaniu lub zapobieganiu ogólnemu opóźnieniu rozwojowemu u dzieci
GB201617908D0 (en) Composition
GB201615908D0 (en) Pharmaceautical composition
GB201607924D0 (en) Composition
GB201619630D0 (en) Composition
GB201618062D0 (en) Composition
GB201616785D0 (en) Composition
GB201616772D0 (en) Composition
GB201616654D0 (en) Composition
GB201615463D0 (en) Composition
GB201615461D0 (en) Composition
GB201615383D0 (en) Composition
GB201615045D0 (en) Composition
GB201614231D0 (en) Composition
GB201613992D0 (en) Composition